Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.22.1
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series A Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2020 $ 538,109 $ 127,159 $ 42,515,999 $ (44,229,106) $ (1,047,839)
Beginning balance, shares at Dec. 31, 2020 538,109,409 127,159,464      
Conversion of Series A Preferred Stock to Common Stock $ (9,680) $ 9,680
Conversion of Series A Preferred Stock to Common Stock, shares (9,679,834) 9,679,834      
Net loss (1,407,674) (1,407,674)
Ending balance at Mar. 31, 2021 $ 528,429 $ 136,839 42,515,999 (45,636,780) (2,455,513)
Ending balance, shares at Mar. 31, 2021 528,429,575 136,839,298      
Beginning balance at Dec. 31, 2021 $ 501,887 $ 164,199 43,700,084 (49,028,413) (4,662,243)
Beginning balance, shares at Dec. 31, 2021 501,887,534 164,199,792      
Conversion of Series A Preferred Stock to Common Stock $ (3,658) $ 3,658
Conversion of Series A Preferred Stock to Common Stock, shares (3,657,730) 3,657,730      
Inducement expense 3,024,872 3,024,872
Conversion of warrants to Common Stock $ 83,580 1,086,530 1,170,110
Conversion of warrants to Common Stock, shares   83,579,296      
Share based compensation 226,079 226,079
Net loss (3,891,783) (3,891,783)
Ending balance at Mar. 31, 2022 $ 498,229 $ 251,437 $ 48,037,565 $ (52,920,196) $ (4,132,965)
Ending balance, shares at Mar. 31, 2022 498,229,804 251,436,818